DE69101651T2 - Pharmazeutische Zusammensetzung, welche eine depigmentierende und eine der Photoalterung entgegenwirkende Aktivität hat. - Google Patents

Pharmazeutische Zusammensetzung, welche eine depigmentierende und eine der Photoalterung entgegenwirkende Aktivität hat.

Info

Publication number
DE69101651T2
DE69101651T2 DE69101651T DE69101651T DE69101651T2 DE 69101651 T2 DE69101651 T2 DE 69101651T2 DE 69101651 T DE69101651 T DE 69101651T DE 69101651 T DE69101651 T DE 69101651T DE 69101651 T2 DE69101651 T2 DE 69101651T2
Authority
DE
Germany
Prior art keywords
combination
activity
pharmaceutical composition
azelaic
photoaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69101651T
Other languages
English (en)
Other versions
DE69101651D1 (de
Inventor
Ruggero Caputo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schering SpA
Cilag SpA
Original Assignee
Schering SpA
Cilag SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering SpA, Cilag SpA filed Critical Schering SpA
Publication of DE69101651D1 publication Critical patent/DE69101651D1/de
Application granted granted Critical
Publication of DE69101651T2 publication Critical patent/DE69101651T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
DE69101651T 1990-02-20 1991-02-12 Pharmazeutische Zusammensetzung, welche eine depigmentierende und eine der Photoalterung entgegenwirkende Aktivität hat. Expired - Lifetime DE69101651T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT01942290A IT1242478B (it) 1990-02-20 1990-02-20 Composizioni farmaceutiche ad attivita' depigmentante e contro il danneggiamento cutaneo fotoindotto.

Publications (2)

Publication Number Publication Date
DE69101651D1 DE69101651D1 (de) 1994-05-19
DE69101651T2 true DE69101651T2 (de) 1994-08-11

Family

ID=11157744

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69101651T Expired - Lifetime DE69101651T2 (de) 1990-02-20 1991-02-12 Pharmazeutische Zusammensetzung, welche eine depigmentierende und eine der Photoalterung entgegenwirkende Aktivität hat.

Country Status (14)

Country Link
EP (1) EP0443413B1 (de)
JP (1) JPH08239320A (de)
KR (1) KR910021235A (de)
AT (1) ATE104144T1 (de)
AU (1) AU7118091A (de)
CA (1) CA2036678A1 (de)
DE (1) DE69101651T2 (de)
DK (1) DK0443413T3 (de)
IE (1) IE910558A1 (de)
IL (1) IL97271A0 (de)
IT (1) IT1242478B (de)
NZ (1) NZ237137A (de)
PT (1) PT96814B (de)
ZA (1) ZA911222B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547989A (en) * 1994-08-19 1996-08-20 Schering-Plough Healthcare Products, Inc. Compositions for treating corns and calluses
US20050226899A1 (en) * 2004-04-08 2005-10-13 Mauro Castiglioni Cosmetic mask composition
DE102006004804A1 (de) 2006-01-23 2007-07-26 Intendis Gmbh Verwendung von Alkandicarbonsäuren und Retinoiden zur Behandlung entzündlicher Hauterkrankungen
US20100273756A1 (en) * 2009-04-27 2010-10-28 Reza Babapour Adjunctive formulation and methods for palliation of fine wrinkles, mottled hyperpigmentation, tactile roughness of facial skin and related disorders
WO2012053009A2 (en) * 2010-10-21 2012-04-26 Cadila Healthcare Limited Pharmaceutical compositions comprising skin whitening agents
EP3359147B1 (de) 2015-07-30 2023-05-03 Curology, Inc. Zusammensetzungen und verfahren zur behandlung von akne und lichtalterung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
DE3623862A1 (de) * 1986-07-11 1988-01-21 Schering Ag Verwendung von dicarbonsaeuren mit 7 - 13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur topischen behandlung von rosazea
JP2565513B2 (ja) * 1987-09-25 1996-12-18 三省製薬株式会社 メラニン生成抑制外用薬剤

Also Published As

Publication number Publication date
KR910021235A (ko) 1991-12-20
ZA911222B (en) 1991-11-27
JPH08239320A (ja) 1996-09-17
PT96814B (pt) 1998-07-31
EP0443413A1 (de) 1991-08-28
IL97271A0 (en) 1992-05-25
IT9019422A1 (it) 1991-08-21
NZ237137A (en) 1992-04-28
ATE104144T1 (de) 1994-04-15
IT1242478B (it) 1994-03-17
PT96814A (pt) 1991-10-31
DE69101651D1 (de) 1994-05-19
CA2036678A1 (en) 1991-08-21
IT9019422A0 (it) 1990-02-20
EP0443413B1 (de) 1994-04-13
AU7118091A (en) 1991-08-22
IE910558A1 (en) 1991-08-28
DK0443413T3 (da) 1994-07-25

Similar Documents

Publication Publication Date Title
ATE89723T1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
IT1105040B (it) 3-1h-tetrazol-5-il-4h-pirido 1,2-a pirimidin-4-oni sostituiti utili in particolare come agenti terapeutici per inibire le reazioni allergiche e procedimento per la produzione dei detti derivati
ATE103914T1 (de) Neue thienylcarbonsaeureester von aminoalkoholen, ihre quaternierungsprodukte sowie die herstellung und verwendung dieser verbindungen.
ATE126433T1 (de) Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
NO905264D0 (no) Fremgangsmaate for fremstilling av biologisk aktivt protein
EP0053448A3 (en) Pre-shampoo type hair treatment composition
ATE145136T1 (de) Verwendung von ketoconazol und ein retinoid zur behandlung der akne vulgaris
ATE183075T1 (de) Retinoid enthaltendes mittel
DE69825887D1 (de) Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebs
DE69101651T2 (de) Pharmazeutische Zusammensetzung, welche eine depigmentierende und eine der Photoalterung entgegenwirkende Aktivität hat.
ATE138260T1 (de) Kosmetisches mittel
NO175885C (no) Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling
DE59206924D1 (de) Ein flurbiprofen enthaltendes akutarzneimittel und seine verwendung
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
DE59304087D1 (de) Placentaextrakt und Verfahren zu seiner Herstellung
ATE102019T1 (de) Mittel zur kosmetischen oder pharmazeutischen verwendung.
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
MX19953A (es) Procedimiento para la preparacion de nuevas benzo tiopiranilaminas, producto obtenido y composicion farmaceutica que lo incluye.
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
ATE86611T1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
ATE116544T1 (de) Zusammensetzung und verwendung dieser zusammensetzung zur herstellung eines arzneimittels für die behandlung von durch wärme- und lichtstrahlung verursachten verletzungen.
DE69008761T2 (de) Retinsäureester von D-Desosamin, Verfahren zu deren Herstellung und ihre Verwendung in der Human- oder Veterinärmedizin und in der Kosmetik.
DE68915750T2 (de) Kathecholverbindungen, verfahren zur herstellung und arzneimittelzubereitung, die diese enthält.
Deranleau et al. Epinephrine-Chlortetracycline Induced Arrhythmia in the Isolated Rat Heart
ATE108653T1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels für die behandlung von knochenverletzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition